Search Results - "VIALLARD, F"

Management of hypogammaglobulinemia by Viallard, J-F

“…Hypogammaglobulinemia (hypoγ) is defined as a serum IgG level < 7 g/L. It is most often detected on serum protein electrophoresis. Given the existence of…”
Get full text

Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects by Grimaldi‐Bensouda, L., Guillemot, D., Godeau, B., Bénichou, J., Lebrun‐Frenay, C., Papeix, C., Labauge, P., Berquin, P., Penfornis, A., Benhamou, P.‐Y., Nicolino, M., Simon, A., Viallard, J.‐F., Costedoat‐Chalumeau, N., Courcoux, M.‐F., Pondarré, C., Hilliquin, P., Chatelus, E., Foltz, V., Guillaume, S., Rossignol, M., Abenhaim, L.

“…Objectives The aim of this study was to investigate whether the quadrivalent human papillomavirus (HPV) vaccine Gardasil is associated with a change in the…”
Get full text

Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects by Dhunputh, C., Ducassou, S., Fernandes, H., Picard, Capucine, Rieux-Laucat, Frédéric, Viallard, J.-F., Lazaro, E., Hermine, O., Jouvray, M., Machelard, I., Lambilliotte, A., Malphettes, M., Moshous, D., Neven, B., Gauthier, A., Garnier, N., Leblanc, T., Landman-Parker, J., Leverger, G., Aladjidi, N.

Get full text

HHV-8 Related immunological and hematological diseases by Blaison, F, Galtier, J, Parrens, M, Viallard, J-F, Boutboul, D

“…HHV-8 is an oncogenic Gammaherpesvirinae discovered in 1994 during the HIV pandemic. It is the causative agent of Kaposi's sarcoma, and is also associated with…”
Get full text

Fasciitis secondary to systemic necrotizing vasculitis by Prot-Leurent, C, Martin-Negrier, M -L, Lazaro, E, Delbrel, X, Viallard, J -F

Get full text

Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia by Tuffigo, M., Lazaro, E., James, C., Subtil, C., Viallard, J.-F., Fiore, M.

“…NO ABSTRACT - Immune thrombocytopenic purpura (ITP) is caused by circulating antibodies that react with target antigens on the platelet membrane [1]. In very…”
Get full text

A multicentre, prospective, non-randomized, sequential, open-label trial to demonstrate the bioequivalence between intravenous immunoglobulin new generation (IGNG) and standard IV immunoglobulin (IVIG) in adult patients with primary immunodeficiency (PID) by Viallard, J.-F., Brion, J.-P., Malphettes, M., Durieu, I., Gardembas, M., Schleinitz, N., Hoarau, C., Lazaro, E., Puget, S.

“…To demonstrate the bioequivalence between 2 intravenous immunoglobulin (IVIG) preparations, TEGELINE® and ClairYg®, a ready-to-use 5% IVIG, in primary…”
Get full text

P1632: PROSPECTIVE OBSERVATIONAL STUDY IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) TREATED WITH TPO‐R AGONISTS (TPO‐RA): ELTROMBOPAG (EPAG) AND ROMIPLOSTIM (ROMI) ‐ THE PEPITE STUDY by Chèze, S., Quittet, P., Adoue, D., Viallard, J.‐F., Sève, P., Bonnotte, B., Laribi, K., Tardy, S., Henique, H., Hamidou, M., Hacini, M., Santagostino, A., Leclerc‐Teffahi, S., Aroichane, M., Filipovics, A., Brini, F., Velasquez Giron, H., Malatesta, A., Michel, M.

Get full text

Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients by Contis, A., Gensous, N., Viallard, J.F., Goizet, C., Léauté‐Labrèze, C., Duffau, P.

Get full text

Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome by Grimaldi-Bensouda, Lamiae, Nordon, Clémentine, Michel, Marc, Viallard, Jean-François, Adoue, Daniel, Magy-Bertrand, Nadine, Durand, Jean-Marc, Quittet, Philippe, Fain, Olivier, Bonnotte, Bernard, Morin, Anne-Sophie, Morel, Nathalie, Costedoat-Chalumeau, Nathalie, Pan-Petesch, Brigitte, Khellaf, Mehdi, Perlat, Antoinette, Sacre, Karim, Lefrere, François, Abenhaim, Lucien, Godeau, Bertrand

“…This prospective observational cohort study aimed to explore the clinical features of incident immune thrombocytopenia in adults and predictors of outcome,…”
Get full text

Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial by Viallard, J F, Agape, P, Barlogis, V, Cozon, G, Faure, C, Fouyssac, F, Gaud, C, Gourin, M P, Hamidou, M, Hoarau, C, Husseini, F, Ojeda-Uribe, M, Pavic, M, Pellier, I, Perlat, A, Schleinitz, N, Slama, B

“…Although Hizentra is indicated for immunoglobulin replacement therapy in patients with primary and secondary immunodeficiencies, phase III trials have focused…”
Get full text

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia by Khellaf, Mehdi, Viallard, Jean-François, Hamidou, Mohamed, Cheze, Stéphane, Roudot-Thoraval, Françoise, Lefrere, François, Fain, Olivier, Audia, Sylvain, Abgrall, Jean-François, Michot, Jean-Marie, Dauriac, Charles, Lefort, Sophie, Gyan, Emmanuel, Niault, Mathilde, Durand, Jean-Marc, Languille, Laetitia, Boutboul, David, Bierling, Philippe, Michel, Marc, Godeau, Bertrand

“…Romiplostim and eltrombopag, the first thrombopoietic receptor-agonists with demonstrated efficacy against immune thrombocytopenia in prospective controlled…”
Get full text

Common variable immunodeficiency disorders: Updated diagnostic criteria and genetics by Fieschi, C, Viallard, J-F

“…Common variable immunodeficiency disorders (CVID) are a heterogeneous group of conditions with hypogammaglobulinemia as the common denominator. These are the…”
Get full text

Usefulness of combined nerve and muscle biopsy in the diagnosis of amyloid neuropathy--a study of 6 new cases by Vital, C, Lagueny, A, Mercie, P, Viallard, J-F, Delabrousse-Mayoux, J-P, Vital, A

“…Most cases of familial amyloid polyneuropathy are identified by molecular genetic analysis of the transthyretin (TTR) gene. However, it is not uncommon to find…”
Get more information

Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: A study of 12 cases by Gueuning, C., Lazaro, E., Dupuy, H., Leonard, C., Greib, C., Prot‐Leurent, C., Riviere, E., Viallard, J. F.

“…Objectives Common Variable Immunodeficiency Disorders (CVID) and Large Granular Lymphocytes leukemia (LGLL) exhibit diverse clinical manifestations including…”
Get full text

Management of multirefractory immune thrombocytopenia by Mahévas, M, Audia, S, Viallard, J-F

“…Multirefractory immune thrombocytopenia (ITP) is defined by the absence of response to TPO receptor agonists, rituximab and splenectomy (or contraindicated or…”
Get full text

HLA‐DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus by Viallard, J. F., Bloch‐Michel, C., Neau‐Cransac, M., Taupin, J. L., Garrigue, S., Miossec, V., Mercie, P., Pellegrin, J. L., Moreau, J. F.

“…A major problem in the management of SLE patients is to predict a flare or to distinguish between active and quiescent disease. Serological markers are widely…”
Get full text

Oral erosive lichen planus and Good's syndrome: just a coincidence or a direct link between the two diseases? by Seneschal, J, Orlandini, V, Duffau, P, Viallard, JF, Pellegrin, JL, Doutre, MS, Beylot-Barry, M

Get full text

Common variable immunodeficiency disorders: Part 2. Updated clinical manifestations and therapeutic management by Viallard, J F, Lebail, B, Begueret, H, Fieschi, C

“…Common variable immunodeficiency disorders (CVID) are the most common symptomatic primary antibody deficiency in adults with an estimated prevalence of…”
Get full text

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution by Cabagnols, X, Defour, J P, Ugo, V, Ianotto, J C, Mossuz, P, Mondet, J, Girodon, F, Alexandre, J H, Mansier, O, Viallard, J F, Lippert, E, Murati, A, Mozziconacci, M J, Saussoy, P, Vekemans, M C, Knoops, L, Pasquier, F, Ribrag, V, Solary, E, Plo, I, Constantinescu, S N, Casadevall, N, Vainchenker, W, Marzac, C, Bluteau, O

Get full text